CSF osteopontin decreased by 65 ng/mL ( 95 % confidence interval 34-96 ng/mL ; p = 0.0004 ) from baseline to week 60 in conjunction with decreases in other CSF biomarkers of inflammation , axonal damage , and demyelination .